Researchers have identified the specific mechanism that triggers resistance to vancomycin. A new study led by the scientific director of the Michael G. DeGroote Institute for Infectious Disease ...

Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. The bactericidal action of vancomycin results primarily from inhibition of cell-wall ...

“We are encouraged by the results of this AD trial exploring how targeting the disease from different angles with different mechanisms of action impacts disease markers,” said Kreesten ...

Article continues below Dale Boger, co-chair of TSRI’s Department of Chemistry, said the new vancomycin was the first antibiotic to have three independent “mechanisms of action” to kill ...

Patients receiving oral vancomycin therapy were identified as having CDAD, the only indication for this drug. Each case subject was matched with up to 10 control subjects. Neither the cases nor the ...